---
layout: post
title: "奥翔药业股东拟合计减持不超5.48%股份"
date: 2022-04-06 22:42:05 +0800
categories: shanghaizhengquanbao·zhongguozhengquanwang
tags: 上海证券报·中国证券网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.603229" data-code="603229|1|1" data-code2="603229|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.603229&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 603229_0" data-code="K 603229|1|1" data-code2="K 603229|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>奥翔药业公告，控股股东、实控人、董事长、总经理郑志国，董事刘兵，董事、副总经理张华东，股东奥翔投资、众翔投资拟合计减持不超5.48%公司股份。其中郑志国拟自本公告发布之日起15个交易日后的6个月内减持不超4.01%股份。上述减持主体无一致行动人。<br /></p><p class="em_media">（文章来源：上海证券报·中国证券网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202204062333897141>

[返回上海证券报·中国证券网新闻](//finews.withounder.com/category/shanghaizhengquanbao·zhongguozhengquanwang.html)｜[返回首页](//finews.withounder.com/)